Metoprolol and <i>CYP2D6</i>: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes

Metoprolol and <i>CYP2D6</i>: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes

Metoprolol is a medication commonly utilized in select patients to achieve a reduction in heart rate, systolic blood pressure, or other indications. A majority of metoprolol metabolism occurs via <i>CYP2D6</i>. Decreased expression of the CYP2D6 enzyme increases the concentration of meto...

Full description

Bibliographic Details
Main Authors:	Savannah Collett, Amanda Massmann, Natasha J. Petry, Joel Van Heukelom, April Schultz, Tadd Hellwig, Jordan F. Baye
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Journal of Personalized Medicine
Subjects:	pharmacogenomics <i>CYP2D6</i> beta blocker phenoconversion
Online Access:	https://www.mdpi.com/2075-4426/13/3/416

Similar Items

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
by: Sam Mostafa, et al.
Published: (2021-08-01)

Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall
by: Joshua Russell, et al.
Published: (2023-01-01)

Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
by: Joel Van Heukelom, et al.
Published: (2023-11-01)

Precision medication: An illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics
by: Kevin T. Bain, et al.
Published: (2020-02-01)

Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults
by: Mollie Walton, et al.
Published: (2024-03-01)

A Review of the Important Role of <i>CYP2D6</i> in Pharmacogenomics
by: Christopher Taylor, et al.
Published: (2020-10-01)

Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population
by: Kristine Ashcraft, et al.
Published: (2022-11-01)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
by: Sylvia D. Klomp, et al.
Published: (2020-09-01)

The Evaluation of <i>CYP2D6, CYP2C9, CYP2C19</i>, and <i>CYP2B6</i> Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics
by: Arianna Giorgetti, et al.
Published: (2023-05-01)

The impact of CYP2C19 genotype on phenoconversion by concomitant medication
by: Laura M. de Jong, et al.
Published: (2023-06-01)

Impact of Obesity and Bariatric Surgery on Metabolic Enzymes and P-Glycoprotein Activity Using the Geneva Cocktail Approach
by: Hengameh Ghasim, et al.
Published: (2023-06-01)

Determination of the Duplicated <i>CYP2D6</i> Allele Using Real-Time PCR Signal: An Alternative Approach
by: Mazen A. Atiq, et al.
Published: (2023-05-01)

Involvement of <i>CYP51A</i> and <i>CYP51B</i> in Growth, Reproduction, Pathogenicity, and Sensitivity to Fungicides in <i>Colletotrichum siamense</i>
by: Shuodan Hu, et al.
Published: (2023-01-01)

Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants
by: Antón Álvarez, et al.
Published: (2010-09-01)

Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
by: Manon G. den Uil, et al.
Published: (2023-08-01)

Psychoactive Medication, Violence, and Variant Alleles for Cytochrome P450 Genes
by: Selma J. M. Eikelenboom-Schieveld, et al.
Published: (2021-05-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study
by: Maria L. Ricardo-Silgado, et al.
Published: (2022-07-01)

Identification and Functional Characterization of CYP4D2 Putatively Associated with β-Cypermethrin Detoxification in <i>Phortica okadai</i>
by: Lingjun Wang, et al.
Published: (2022-12-01)

Simple and Robust Detection of <i>CYP2D6</i> Gene Deletions and Duplications Using <i>CYP2D8P</i> as Reference
by: Jens Borggaard Larsen, et al.
Published: (2022-01-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

Metoprolol treatment of dual cocaine and bupropion cardiovascular and central nervous system toxicity
by: John R. Richards, et al.
Published: (2019-03-01)

<i>CYP2D6</i> and <i>CYP2C19</i> Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia
by: Malcolm Forbes, et al.
Published: (2023-10-01)

Effect of Antibiotic Susceptibility and <i>CYP3A4/5</i> and <i>CYP2C19</i> Genotype on the Outcome of Vonoprazan-Containing <i>Helicobacter pylori</i> Eradication Therapy
by: Mitsushige Sugimoto, et al.
Published: (2020-09-01)

An Investigation of O-Demethyl Tramadol/Tramadol Ratio for Cytochrome P450 2D6 Phenotyping: The CYTRAM Study
by: Blandine De La Gastine, et al.
Published: (2022-10-01)

Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca Effects of metoprolol tartrate therapy in patients with heart failure
by: José Albuquerque de Figueiredo Neto, et al.
Published: (2006-09-01)

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study
by: Køber Lars, et al.
Published: (2011-10-01)

Association of <i>CYP2C19, CYP2D6</i> and <i>CYP3A4</i> Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients
by: Marielle M. Macêdo, et al.
Published: (2023-06-01)

Feasibility of Community Pharmacist-Initiated and Point-of-Care <i>CYP2C19</i> Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors
by: Amar D. Levens, et al.
Published: (2023-02-01)

Metoprolol rescues endothelial progenitor cell dysfunction in diabetes
by: Lang Yan, et al.
Published: (2020-07-01)

CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
by: Kuntheavy Ing Lorenzini, et al.
Published: (2021-08-01)

Genetic Diversity of Cytochrome P450s <i>CYP6M2</i> and <i>CYP6P4</i> Associated with Pyrethroid Resistance in the Major Malaria Vectors <i>Anopheles coluzzii</i> and <i>Anopheles gambiae</i> from Yaoundé, Cameroon
by: Yvan Fotso-Toguem, et al.
Published: (2022-12-01)

Characterization of Novel <i>CYP2D6</i> Alleles across Sub-Saharan African Populations
by: Wendy Y. Wang, et al.
Published: (2022-09-01)

Clinical Impact of the <i>CYP2C19</i> Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome
by: Teresa T. Ho, et al.
Published: (2023-02-01)

CYP and SXR gene polymorphisms influence in opposite ways acute rejection rate in pediatric patients with renal transplant
by: Stefano Turolo, et al.
Published: (2020-05-01)

CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome
by: Mirzaev KB, et al.
Published: (2017-04-01)

Evaluation of changes in cytochrome P450 2C19 activity in type 2 diabetic rats before and after treatment, by using isolated perfused liver model
by: Navid Neyshaburinezhad, et al.
Published: (2020-05-01)

Metoprolol and atenolol in mild-to-moderate chronic heart failure: The comparison of survival benefit
by: Ćelić Vera, et al.
Published: (2005-01-01)

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol
by: Frédérique Rodieux, et al.
Published: (2023-08-01)

Impact of <i>CYP3A5</i>, <i>POR,</i> and <i>CYP2C19</i> Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation
by: Kimitaka Suetsugu, et al.
Published: (2019-05-01)